Foreign-Born Women in U.S. Less Likely to Have Mammograms
Findings remain even after adjusting for common sociodemographic factors.
Findings remain even after adjusting for common sociodemographic factors.
Rates of grade 3/4 AEs and dose reductions/interruptions associated with CDK4/6 + AI therapy were higher in those 75 years and older compared with younger patients.
Get the latest breast cancer treatment regimens with in-depth drug information on therapies such as tamoxifen, trastuzumab, and docetaxel.
Pace of decline slowed from 1.9 percent during 1998 to 2011 to 1.3 percent during 2011 to 2017.
Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.
Using a subset from the GeparOcto trial, researchers sought to determine if IV FCM was superior to physicians’ choice in treating chemotherapy-induced anemia in patients with breast cancer.
A single-institution study is able to reproduce results of previous studies on the use of a scalp cooling system to prevent chemotherapy-induced hair loss in patients with breast cancer receiving anthracycline and/or taxane-based therapies.
A meta-analysis of 222 men with nonmetastatic male breast cancer confirmed that disease stage at diagnosis remains an important prognostic factor.
Patient-specific, individualized coaching was found to provide needed support for patients with recurrent breast cancer.
An evaluation of patient education materials on chemotherapy for breast cancer revealed that many do not meet NIH recommendations.